Gastroparesis treatment options metoclopramide and prucalopride: analysis of the FDA adverse event reporting system (FAERS) database

We aimed to examine the common adverse drug reactions (ADRs) of metoclopramide, FDA-approved for treating many gastrointestinal conditions including gastroparesis, and prucalopride, FDA-approved for treating chronic idiopathic constipation but used off-label for other gastrointestinal conditions including gastroparesis.